Company Overview and News
Buddy Platform Ltd (ASX:BUD) and Ingram Micro Inc. (NYSE:IM) have extended their distribution relationship to Mexico, Brazil and 18 additional Latin American markets.
Buddy Platform Ltd’s (ASX:BUD) building monitoring solution, Buddy Ohm, has been launched in Trinidad & Tobago, Barbados, Bermuda, Aruba, St. Vincent and Panama.
Buddy Platform Ltd (ASX:BUD) is finalising negotiations with Telstra Corporation (ASX:TLS) to make Telstra the primary sales channel for Buddy Ohm across Australia.
Buddy Platform Ltd (ASX:BUD) has successfully raised $23 million via an oversubscribed placement of shares at $0.20 each to new and existing institutional investors.
Buddy Platform Ltd (ASX:BUD) recently secured its largest distribution deal to date, having executed a nationwide resale and distribution agreement with Ingram Micro Canada, part of the world’s largest distributor of technology products.
Buddy Platform Ltd (ASX:BUD) and Digicel, the largest mobile operator in the Caribbean, has reached an agreement to sell, distribute and install Buddy Ohm through Digicel’s sales and operations teams.
Buddy Platform (ASX:BUD) has launched “Buddy Ohm”, a building monitoring solution for monitoring the consumption of electricity, gas, water and other resources in buildings.
Beer brewing behemoth, Anheuser-Busch InBev SA/NV (BUD - Free Report) , alias AB InBev, has recently been in the limelight not only for its massive merger with close rival SABMiller Plc but also due to its string of dismal earnings performance and the consequent slump in stock price. AB InBev is on track with the integration of the recently acquired brewing giant SABMiller. The company is currently in the process of divesting SABMiller assets that it promised as part of the merger deal.
With the massive growth in smart city projects around the world, Buddy Platform has announced "Buddy Ohm", its first end-to-end solution focused on resource monitoring.
The company’s shares are up 8.6% intra-day, currently trading at A$0.063 on the ASX. Buddy is a provider of data aggregation and management platforms for internet of things (IoT) and connected devices. The new contract brings Buddy’s total contracted value with Thor Industries, a manufacturer of recreational vehicles, to A$2.25 million. The project, which builds upon the existing customer relationship between Buddy and the customer, deploys Buddy-powered smart city and connected residential technologies.
2018-04-18 - Asif
History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...
2018-04-16 - Asif
Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...
2018-04-16 - Asif
Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...
2018-04-15 - Asif
Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...
2018-04-12 - Asif
Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...